Coinfection
Tenofovir-containing Regimen Works Better Over Time for HIV/HBV Coinfected People
- Details
- Category: HIV/HBV Coinfection
- Published on Wednesday, 16 September 2015 00:00
- Written by Liz Highleyman
HIV-positive people coinfected with hepatitis B virus (HBV) who were treated with 2 dually-active drugs -- one of them being tenofovir -- responded about as well as people taking only lamivudine or emtricitabine at 24 weeks, but over the longer term those on tenofovir plus either lamivudine or emtricitabine were more likely to maintain undetectable HBV viral load, according to a study published in a recent edition of AIDS.
IAS 2015: HIV and Hepatitis B Coinfected People Can Safely Switch to Simpler TAF Single-Tablet Regimen
- Details
- Category: HIV/HBV Coinfection
- Published on Wednesday, 12 August 2015 00:00
- Written by Liz Highleyman
HIV-positive people with hepatitis B virus (HBV) coinfection maintained HIV viral suppression, maintained or achieved HBV suppression, and showed improvements in kidney and bone markers when they switched to a single-tablet regimen containing the integrase inhibitor elvitegravir and a new safer formulation of tenofovir, according to a late-breaking poster presented at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last month in Vancouver.
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
Coverage of the 2015 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Monday, 02 March 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2015 Conference on Retroviruses and Opportunistic infections (CROI 2015), February 23-26, 2015, in Seattle.
Conference highlights include PrEP and HIV treatment as prevention, hepatitis C treatment for HIV/HCV coinfected people, new antiretroviral drugs, HIV cure research, HIV-related conditions, TB, Ebola virus, and access to care.
HIVandHepatitis.com coverage by topic
3/2/15
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
CROI 2015: Retrovirus Conference Now Underway in Seattle
- Details
- Category: HIV Treatment
- Published on Monday, 23 February 2015 00:00
- Written by HIVandHepatitis.com
The 2015 Conference on Retroviruses and Opportunistic Infections (CROI) takes place this week, February 23-26, at the Washington State Convention Center in Seattle. CROI focuses on HIV treatment, prevention, and basic science. For the past several years it has also included substantial hepatitis C content, and this year will feature presentations on Ebola virus. HIVandHepatitis.com is on site in Seattle all week bringing you news coverage and Twitter updates (@HIVandHepatitis).
IDWeek 2014: HIV and Hepatitis B Coinfection Linked to Hip Fractures
- Details
- Category: HIV/HBV Coinfection
- Published on Wednesday, 22 October 2014 00:00
- Written by Liz Highleyman
People with HIV/HBV coinfection being treated for both diseases had a significantly higher risk of hip fractures than patients with HIV alone or neither virus, according to research presented at IDWeek 2014 last week in Philadelphia.
CROI 2015: Retrovirus Conference Starts Monday in Seattle
- Details
- Category: HIV Treatment
- Published on Friday, 20 February 2015 00:00
- Written by HIVandHepatitis.com
The 2015 Conference on Retroviruses and Opportunistic Infections (CROI) takes place next week, February 23-26, at the Washington State Convention Center in Seattle. CROI focuses on HIV treatment, prevention, and basic science. For the past several years it has also included substantial hepatitis C content, and this year will feature presentations on Ebola virus. HIVandHepatitis.com will be on site in Seattle all week bringing you news coverage and Twitter updates (@HIVandHepatitis).
Tenofovir Usually Suppresses Hepatitis B in HIV/HBV Coinfected People
- Details
- Category: HIV/HBV Coinfection
- Published on Thursday, 03 July 2014 00:00
- Written by Liz Highleyman
Tenofovir led to undetectable hepatitis B virus (HBV) levels in 87% of HIV positive coinfected individuals, and a similar proportion maintained viral suppression over 6 years, according to a study described in the June 20 advance edition of Hepatology.
Web Design and Development by